Tofacitnib for the Treatment of Alopecia Areata and Variants

Key facts

Sponsor

Yale University

Principal Investigator

Brett King, MD

Yale University

Intervention

Tofacitinib Administration(drug)

Enrollment

30 enrolled

Eligibility

18-90 years · All sexes

Timeline

2014 – 2015

Study locations (1)

• Yale University, New Haven, Connecticut, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07533006
  A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
  Eli Lilly and Company
• RECRUITINGPHASE3NCT07435012
  Androgenic Alopecia TH07 Clinical Trial
  Triple Hair Inc
• ENROLLING BY INVITATIONNCT07499713
  Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata
  Istanbul Training and Research Hospital
• RECRUITINGNANCT07422376
  Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands Region
  Charles Mays
• RECRUITINGNCT07226531
  Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US
  Pfizer
• RECRUITINGNANCT07563036
  JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil
  Kasr El Aini Hospital
• RECRUITINGPHASE2NCT07370519
  Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia
  Shenzhen People's Hospital
• ACTIVE NOT RECRUITINGNANCT07520019
  Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning Hair
  Nutra Harmony LLC

See all trials for Alopecia →